Walleye Capital LLC Agios Pharmaceuticals, Inc. Put Options Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $187,340 - $332,044	-6,800 Reduced 62.96%	4,000 $172,000
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $172,692 - $281,961	8,100 Added 300.0%	10,800 $315,000
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $11,982 - $14,718	600 Added 28.57%	2,700 $60,000
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $51,156 - $59,178	2,100 New	2,100 $51,000
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $453,888 - $774,864	-14,400 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $1.01 Million - $1.69 Million	-33,500 Reduced 69.94%	14,400 $688,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $1.12 Million - $1.72 Million	34,600 Added 260.15%	47,900 $1.55 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $267,786 - $394,979	5,800 Added 77.33%	13,300 $663,000
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $344,400 - $507,525	7,500 New	7,500 $506,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.